We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J CEO Won't Take Stand In Risperdal Breast-Growth Trial

Law360, Philadelphia (September 20, 2012, 7:32 PM EDT) -- Johnson & Johnson CEO Alex Gorsky will not be forced to take the stand in a trial set to begin Monday alleging a boy developed breasts after being treated with the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.